These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 3927807)
1. Tocainide: a new oral antiarrhythmic agent. Kutalek SP; Morganroth J; Horowitz LN Ann Intern Med; 1985 Sep; 103(3):387-91. PubMed ID: 3927807 [TBL] [Abstract][Full Text] [Related]
2. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine. Alpert JS; Haffajee CI; Young MD Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205 [TBL] [Abstract][Full Text] [Related]
3. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent. Morganroth J; Nestico PF; Horowitz LN Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446 [TBL] [Abstract][Full Text] [Related]
4. Tocainide. A review of its pharmacological properties and therapeutic efficacy. Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445 [TBL] [Abstract][Full Text] [Related]
5. Tocainide: a new drug for ventricular arrhythmias. Volosin KJ; Greenspon AJ Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938 [No Abstract] [Full Text] [Related]
6. Tocainide: a new oral antiarrhythmic. Hasegawa GR Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308 [TBL] [Abstract][Full Text] [Related]
7. Tocainide for arrhythmias. Med Lett Drugs Ther; 1985 Feb; 27(680):9-11. PubMed ID: 3918240 [No Abstract] [Full Text] [Related]
8. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias. Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias. Ryan W; Engler R; LeWinter M; Karliner JS Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study. Mahapatra RK; Mahapatra D Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347 [TBL] [Abstract][Full Text] [Related]
14. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias. Schwartzkopff B; Schilling G; Simon H Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021 [TBL] [Abstract][Full Text] [Related]
15. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide. Pottage A Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction. Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252 [TBL] [Abstract][Full Text] [Related]
17. On the kinetics and dynamics of tocainide and its metabolites. Ronfeld RA; Wolshin EM; Block AJ Clin Pharmacol Ther; 1982 Mar; 31(3):384-92. PubMed ID: 6800678 [TBL] [Abstract][Full Text] [Related]
18. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine. Snyder DW J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645 [TBL] [Abstract][Full Text] [Related]
19. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation. Uprichard AC; Allen JD; Harron DW J Cardiovasc Pharmacol; 1988 Feb; 11(2):235-41. PubMed ID: 2452320 [TBL] [Abstract][Full Text] [Related]